Fionnuala Doyle

Fionnuala Doyle has extensive work experience in the pharmaceutical industry. Fionnuala is currently serving as the Senior Vice President and Global Head of Commercial Strategy at Amryt Pharma since 2022. Prior to this, they worked at Halozyme, Inc. from 2021 to 2022, where they held the position of SVP, Global Head ENHANZE and GM, Halozyme Therapeutics. From 2019 to 2021, they served as the SVP and Global Head of Commercial and Regions at Biocon Biologics. Fionnuala also has a long tenure at Novartis, where they took on various roles such as Global Head Policy & Health Care Systems, General Manager of Novartis Oncology, General Manager of Oncology, General Manager, Business Unit Head Oncology, and Business Unit Head CNS. Prior to Novartis, Fionnuala worked at Abbott & Menarini Pharmaceuticals as a marketing manager, business development manager, and sales & sales management.

Fionnuala Doyle has a Graduateship in International Business and Marketing from The Marketing Institute of Ireland. Fionnuala also has a Hons Science degree from Trinity College Dublin, with a focus on Chemistry, Biochemistry, Physiology, Clinical Nutrition, and Dietetics.